This report from provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hyperplasia (BPH). Implants are a temporary or permanent solution for men suffering from symptoms caused by prostate enlargement. LSI projects that this market will thrive throughout the forecast period as these devices become more accessible to men seeking relief from BPH.
This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:
- Unit volumes from 2020 to 2026
- Market forecasts from 2020 to 2026
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- BD
- Boston Scientific
- Endotherapeutics
- Fabian
- Olympus
- ProArc
- ProVerum
- Teleflex
- ZenFlow
